/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

B

Benjamin Frey

Universitätsklinikum Erlangen(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

366

Papers

11.4K

Citations

58

h-index

181

i10-index

Benjamin Frey is an academic researcher from Universitätsklinikum Erlangen. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Effects of Radiation Exposure & Immunotherapy and Immune Responses. The author has an h-index of 58, co-authored 312 publications.

ORCID: 0000-0001-6743-3351

Research Topics

Cancer Immunotherapy and Biomarkers Effects of Radiation Exposure Immunotherapy and Immune Responses Phagocytosis and Immune Regulation Radiomics and Machine Learning in Medical Imaging

Papers by this author

works

Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis

2020 · Nature Communications · 447 citations

https://doi.org/10.1038/s41467-020-15831-7

Narges Tajik Michael Frech Oscar Schulz Fabian Schälter

Biological Rationales and Clinical Applications of Temperature Controlled Hyperthermia - Implications for Multimodal Cancer Treatments

2010 · Current Medicinal Chemistry · 96 citations

https://doi.org/10.2174/092986710791959774

Petra Schildkopf Oliver J. Ott Benjamin Frey Martin Wadepohl

Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases

2020 · The American Journal of Human Genetics · 82 citations

https://doi.org/10.1016/j.ajhg.2020.07.001

Stefan Haskamp Heiko Bruns Madelaine Hahn Markus Hoffmann

Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines

2014 · Radiation Oncology · 68 citations

https://doi.org/10.1186/1748-717x-9-89

Yvonne Rubner Carolin Muth Annedore Strnad Anja Derer

Immune biological rationales for the design of combined radio- and immunotherapies

2020 · Cancer Immunology Immunotherapy · 50 citations

https://doi.org/10.1007/s00262-019-02460-3

Michael Häder Benjamin Frey Rainer Fietkau Markus Hecht

Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials

2020 · ESMO Open · 26 citations

https://doi.org/10.1136/esmoopen-2019-000621

Jian‐Guo Zhou Lang Huang Su‐Han Jin Cheng Xu

Research topics

topics

Cancer Immunotherapy and Biomarkers

Effects of Radiation Exposure

Immunotherapy and Immune Responses

Phagocytosis and Immune Regulation

Radiomics and Machine Learning in Medical Imaging

Chat about Author

Papers

Chat

Click to start Chat